U.S. FDA approves first generic version of Mylan's EpiPen
August 16, 2018 at 13:10 PM EDT
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's EpiPen for the emergency treatment of allergic reactions.
